Huda Suliman explains the nuances of drug discovery in ageing research
Lifespan.io (LEAF) - 23-Oct-2019Indications are less clear with anti-ageing compounds than with disease specific drugs
Join the club for FREE to access the whole archive and other member benefits.
President at Icaria Life Sciences contract research organisation
Prior to joining Ichor, Dr. Suliman was manager of research & development at Acumen Detection, LLC., an SRC company. At Acumen, Dr. Suliman developed novel assay technologies for the identification of mastitis causing pathogens as part of a point of need testing system designed for dairy farms. These assay technologies, as part of the system, are patent pending.
Visit website: https://www.leafscience.org/dr-huda-suliman/
See also: Icaria Life Sciences - Ichor Therapeutics' contract research arm focused on aging
Details last updated 15-Nov-2019
Indications are less clear with anti-ageing compounds than with disease specific drugs